{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:48:24Z","timestamp":1793162904022,"version":"4.5.0"},"reference-count":51,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>A library of bile-acid-appended triazolyl aryl ketones was synthesized and characterized by detailed spectroscopic techniques such as 1H and 13C NMR, HRMS and HPLC. All the synthesized conjugates were evaluated for their cytotoxicity at 10 \u00b5M against MCF-7 (human breast adenocarcinoma) and 4T1 (mouse mammary carcinoma) cells. In vitro cytotoxicity studies on the synthesized conjugates against MCF-7 and 4T1 cells indicated one of the conjugate 6cf to be most active against both cancer cell lines, with IC50 values of 5.71 \u00b5M and 8.71 \u00b5M, respectively, as compared to the reference drug docetaxel, possessing IC50 values of 9.46 \u00b5M and 13.85 \u00b5M, respectively. Interestingly, another compound 6af (IC50 = 2.61 \u00b5M) was found to possess pronounced anticancer activity as compared to the reference drug docetaxel (IC50 = 9.46 \u00b5M) against MCF-7. In addition, the potent compounds (6cf and 6af) were found to be non-toxic to normal human embryonic kidney cell line (HEK 293), as evident from their cell viability of greater than 86%. Compound 6cf induces higher apoptosis in comparison to 6af (46.09% vs. 33.89%) in MCF-7 cells, while similar apoptotic potential was observed for 6cf and 6af in 4T1 cells. The pharmacokinetics of 6cf in Wistar rats showed an MRT of 8.47 h with a half-life of 5.63 h. Clearly, these results suggest 6cf to be a potential candidate for the development of anticancer agents.<\/jats:p>","DOI":"10.3390\/molecules26195741","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T22:50:48Z","timestamp":1632351048000},"page":"5741","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Bile-Acid-Appended Triazolyl Aryl Ketones: Design, Synthesis, In Vitro Anticancer Activity and Pharmacokinetics in Rats"],"prefix":"10.3390","volume":"26","author":[{"given":"Devesh S.","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Chemistry, Birla Institute of Technology and Science, Pilani 333 031, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrat","family":"Mazumdar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science, Pilani 333 031, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan S.","family":"Italiya","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science, Pilani 333 031, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Chitkara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science, Pilani 333 031, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Sakhuja","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Birla Institute of Technology and Science, Pilani 333 031, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jama.297.9.953","article-title":"Computed tomography screening and lung cancer outcomes","volume":"297","author":"Bach","year":"2007","journal-title":"Jama"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1126\/science.287.5460.1969","article-title":"Mechanism-based target identification and drug discovery in cancer research","volume":"287","author":"Gibbs","year":"2000","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/qsar.200540213","article-title":"Charting biological and chemical space: PSSC and SCONP as guiding principles for the development of compound collections based on natural product scaffolds","volume":"25","author":"Arve","year":"2006","journal-title":"Qsar Comb. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1016\/j.bmcl.2014.07.030","article-title":"Indolylmethylene benzo [h] thiazolo [2,3-b] quinazolinones: Synthesis, characterization and evaluation of anticancer and antimicrobial activities","volume":"24","author":"Gali","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.ejca.2004.08.021","article-title":"Molecular portraits of breast cancer: Tumour subtypes as distinct disease entities","volume":"40","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"Ca-Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrd1721","article-title":"The rise and rise of drug delivery","volume":"4","author":"Rosen","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5483\/BMBRep.2002.35.1.134","article-title":"Synthetic bile acids: Novel mediators of apoptosis","volume":"35","author":"Kim","year":"2002","journal-title":"Bmb Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S2210-7401(12)70023-2","article-title":"Chemoprevention of colorectal cancer with ursodeoxycholic acid: Cons","volume":"36","author":"Carey","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.gcb.2010.05.005","article-title":"Ursodeoxycholic acid and chemoprevention of colorectal cancer","volume":"34","author":"Serfaty","year":"2010","journal-title":"Gastroenterol. Clin. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S2210-7401(12)70022-0","article-title":"Chemoprevention of colorectal cancer with ursodeoxycholic acid: Pro","volume":"36","author":"Serfaty","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02468874","article-title":"Ursodeoxycholic acid prevents gastrointestinal disorders caused by anticancer drugs","volume":"11","author":"Tatsumura","year":"1981","journal-title":"Jpn. J. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.3390\/nu7053200","article-title":"Anticancer effect of ursodeoxycholic acid in human oral squamous carcinoma HSC-3 cells through the caspases","volume":"7","author":"Pang","year":"2015","journal-title":"Nutrients"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/13102818.2014.927973","article-title":"Metal Zn (II), Cu (II), Ni (II) complexes of ursodeoxycholic acid as putative anticancer agents","volume":"28","author":"Dyakova","year":"2014","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/cmdc.201800756","article-title":"Dihydroartemisinin\u2013bile acid hybridization as an effective approach to enhance dihydroartemisinin anticancer activity","volume":"14","author":"Marchesi","year":"2019","journal-title":"ChemMedChem"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jsbmb.2013.05.011","article-title":"Current status on development of steroids as anticancer agents","volume":"137","author":"Gupta","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1002\/asia.201100432","article-title":"Click chemistry: 1,2,3-triazoles as pharmacophores","volume":"6","author":"Agalave","year":"2011","journal-title":"Chem. Asian J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.steroids.2011.05.002","article-title":"Synthesis of novel steroidal 17\u03b1-triazolyl derivatives via Cu (I)-catalyzed azide-alkyne cycloaddition, and an evaluation of their cytotoxic activity in vitro","volume":"76","author":"Frank","year":"2011","journal-title":"Steroids"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.bmcl.2015.04.096","article-title":"Click reaction based synthesis, antimicrobial, and cytotoxic activities of new 1,2,3-triazoles","volume":"25","author":"Aly","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3762\/bjoc.11.208","article-title":"Synthesis, antimicrobial and cytotoxicity evaluation of new cholesterol congeners","volume":"11","author":"Aly","year":"2015","journal-title":"Beilstein J. Org. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.3390\/molecules18077661","article-title":"Schmeda-Hirschmann, G. 1,2,3-Triazole-substituted oleanolic acid derivatives: Synthesis and antiproliferative activity","volume":"18","author":"Pertino","year":"2013","journal-title":"Molecules"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1039\/C4OB01605J","article-title":"A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: Design, synthesis, and biological evaluation","volume":"13","author":"Wei","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00044-018-2213-x","article-title":"Novel triazoles of 3-acetylbetulin and betulone as anticancer agents","volume":"27","author":"Chrobak","year":"2018","journal-title":"Med. Chem. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejmech.2013.03.028","article-title":"Synthesis of 3-O-propargylated betulinic acid and its 1, 2, 3-triazoles as potential apoptotic agents","volume":"63","author":"Majeed","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sidova, V., Zoufaly, P., Pokorny, J., Dzubak, P., Hajduch, M., Popa, I., and Urban, M. (2017). Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171621"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1016\/j.bmc.2010.08.023","article-title":"Synthesis, cytotoxicity and liposome preparation of 28-acetylenic betulin derivatives","volume":"18","author":"Csuk","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ardp.201000232","article-title":"Synthesis, encapsulation and antitumor activity of new betulin derivatives","volume":"344","author":"Csuk","year":"2011","journal-title":"Arch. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.steroids.2012.11.016","article-title":"Preparation, preliminary screening of new types of steroid conjugates and their activities on steroid receptors","volume":"78","year":"2013","journal-title":"Steroids"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejmech.2015.04.045","article-title":"Cu (I) catalyzed alkyne-azide 1, 3-dipolar cycloaddition (CuAAC): Synthesis of 17\u03b1-[1-(substituted phenyl)-1,2,3-triazol-4-yl]-19-nor-testosterone-17\u03b2-yl acetates targeting progestational and antipro-liferative activities","volume":"97","author":"Mohamed","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.3390\/molecules16064786","article-title":"Synthesis and in vitro antiproliferative activity of novel androst-5-ene triazolyl and tetrazolyl derivatives","volume":"16","author":"Kadar","year":"2011","journal-title":"Molecules"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Molnar, J., Frank, E., Minorics, R., Kadar, Z., Ocsovszki, I., Schonecker, B., Wolfling, J., and Zupko, I. (2015). A click approach to novel D-ring-substituted 16\u03b1-triazolylestrone derivatives and characterization of their antiproliferative properties. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118104"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bmc.2012.01.008","article-title":"A facile \u2018click\u2019approach to novel 15\u03b2-triazolyl-5\u03b1-androstane derivatives, and an evaluation of their antiproliferative activities in vitro","volume":"20","author":"Kadar","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1039\/c1ob06086d","article-title":"Efficient approach to novel 1\u03b1-triazolyl-5\u03b1-androstane derivatives as potent antiproliferative agents","volume":"9","author":"Kadar","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3998\/ark.5550190.0013.320","article-title":"Efficient synthesis of novel A-ring-substituted 1, 2, 3-triazolylcholestane derivatives via catalytic azide-alkyne cycloaddition","volume":"3","author":"Kadar","year":"2012","journal-title":"Arkivoc"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.steroids.2014.05.020","article-title":"Synthesis, cytotoxic effects and tubulin polymerization inhibition of 1,4-disubstituted 1,2,3-triazole analogs of 2-methoxyestradiol","volume":"87","author":"Solum","year":"2014","journal-title":"Steroids"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.steroids.2010.02.015","article-title":"D-ring substituted 1,2,3-triazolyl 20-keto pregnenanes as potential anticancer agents: Synthesis and biological evaluation","volume":"75","author":"Banday","year":"2010","journal-title":"Steroids"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Navacchia, M.L., Marchesi, E., and Perrone, D. (2021). Bile acid conjugates with anticancer activity: Most recent research. Molecules, 26.","DOI":"10.3390\/molecules26010025"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Navacchia, M.L., Marchesi, E., Mari, L., Chinaglia, N., Gallerani, E., Gavioli, R., Capobianco, M.L., and Perrone, D. (2017). Rational Design of Nucleoside\u2013Bile Acid Conjugates Incorporating a Triazole Moiety for Anticancer Evaluation and SAR Exploration. Molecules, 22.","DOI":"10.3390\/molecules22101710"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1039\/c3nj00513e","article-title":"Synthesis and in vitro cytotoxicity of deoxyadenosine\u2013bile acid conjugates linked with 1,2,3-triazole","volume":"37","author":"Perrone","year":"2013","journal-title":"New J. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.steroids.2018.09.006","article-title":"Clickable conjugates of bile acids and nucleosides: Synthesis, characterization, in vitro anticancer and antituberculosis studies","volume":"139","author":"Agarwal","year":"2018","journal-title":"Steroids"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11030-017-9797-9","article-title":"Synthesis and evaluation of bile acid amides of \u03b1-cyanostilbenes as anticancer agents","volume":"22","author":"Agarwal","year":"2018","journal-title":"Mol. Divers."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.steroids.2015.12.022","article-title":"Synthesis, characterization and biological evaluation of bile acid-aromatic\/heteroaromatic amides linked via amino acids as anti-cancer agents","volume":"107","author":"Agarwal","year":"2016","journal-title":"Steroids"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1039\/b809221d","article-title":"Synthesis and biological evaluation of bile acid dimers linked with 1, 2, 3-triazole and bis-\u03b2-lactam","volume":"6","author":"Vatmurge","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1007\/s00044-011-9723-0","article-title":"Petra, osiris and molinspiration (POM) together as a successful support in drug design: Antibacterial activity and biopharmaceutical characterization of some azo Schiff bases","volume":"21","author":"Jarrahpour","year":"2012","journal-title":"Med. Chem. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_47","first-page":"2020","article-title":"1,3-Disubstitutedureaderivatives: Synthesis, antimicrobial activity evaluation and in silico studies","volume":"102","author":"Krishna","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1208\/pt070235","article-title":"Applying pattern recognition methods to analyze the molecular properties of a homologous series of nitrogen mustard agents","volume":"7","author":"Bartzatt","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejps.2017.02.009","article-title":"Enhanced oral bioavailability of docetaxel in rats combined with myricetin: In situ and in vivo evidences","volume":"101","author":"Hao","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1021\/acs.molpharmaceut.8b00228","article-title":"Cholesterol and Morpholine Grafted Cationic Amphiphilic Copolymers for miRNA-34a Delivery","volume":"15","author":"Sharma","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.nano.2018.09.014","article-title":"Self-assembling lisofylline-fatty acid conjugate for effective treatment of diabetes mellitus","volume":"15","author":"Italiya","year":"2019","journal-title":"Nanomedicine"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/19\/5741\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:03:21Z","timestamp":1760166201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/19\/5741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":51,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["molecules26195741"],"URL":"https:\/\/doi.org\/10.3390\/molecules26195741","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]}}}